High materiality7/10
Hemab Therapeutics price target raised to $60 from $52 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises COAG price target to $60 from $52; current price $51.91.
- Wainwright raises COAG PT to $60
- Current price $51.91
Key facts
- 01
Target: $60
- 02
Posted price: $51.91
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.